Lifestyle interventions for metabolic associated fat hepatitis
Lifestyle interventions for metabolism-related fatty liver disease (MAFLD) are an important part of the treatment and management of the disease.
1. The reduction of body weight management (especially fat) is at the heart of MAFLD management. The reduction in body weight is proportional to the improvement in liver-related outcomes. The guidelines recommend a 5 per cent reduction in body weight and 5 per cent reduction in liver fat variability, 7 per cent reduction in fat hepatitis and 10 per cent reversal of fibrosis to a certain extent. For MAFLD patients with normal weight, a 3 to 5 per cent weight reduction improves heart metabolic health and reduces 50 per cent of MAFLD.
2. A diet adjustment proposal for MAFLD patients to adjust the diet to reduce intake of saturated fats, cholesterol, refined carbohydrates, sugared beverages and deep-processed foods associated with the MFLD epidemic. At the same time, the dietary patterns can reduce the MAFLD risk by increasing the healthy diet index, the pressure diet score, the Mediterranean diet score and the intake of foods that are highly resistant to oxidizing (fresh fruit, green vegetables, whole grains, foods rich in thorium-3 unsaturated fatty acids).
3. Campaigns for increased physical activity are another key aspect of MAFLD management. It is recommended that patients reduce their energy intake by 500-1,000 kcal per day to gradually reduce weight and liver fat content and improve IR (insulin resistance) and liver function indicators.
Reducing alcohol consumption, especially when it is sobering, has multiple benefits for the liver and body. Alcohol can increase liver damage, so avoiding alcohol is an important lifestyle adjustment for MAFLD patients.
5. The cessation of smoking is also part of lifestyle interventions, as smoking is associated with a variety of health problems, including cardiovascular diseases and cancer.
Blood sugar management is very important for patients with diabetes and for strict control of blood sugar levels. MAFLD patients need to control blood sugar through diet, exercise and, if necessary, medication.
Blood resin management controls blood resin levels through healthy lifestyles and, if necessary, drug treatment. The choice of lipid-reducing drugs needs to balance the benefits of cardiovascular, kidney and liver, with attention to the prevention of obese-trigger-related tumours.
MAFLD treatment requires multidisciplinary collaboration, including professionals such as doctors, nutritionists, sports professionals, psychologists and caregivers. Together, they provide education, resources and motivation for patients to help them improve and maintain their health and well-being. These integrated lifestyle interventions can effectively improve the liver health of MAFLD patients, reduce the risk of heart metabolic diseases and improve the quality of life.
